Gunpo-si, South Korea

Yong Ho Sun

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Boryung Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yong Ho Sun. Retrieved from https://idiyas.com/inventor/yong-ho-sun

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yong Ho Sun - Innovator in PI3K Inhibitor Development

Introduction

Yong Ho Sun is a notable inventor based in Gunpo-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as PI3K inhibitors. His innovative approach has led to advancements that simplify the preparation processes of these important compounds.

Latest Patents

Yong Ho Sun holds a patent for a method for preparing a compound as a PI3K inhibitor and an intermediate compound for preparing the same. This invention provides a streamlined method that reduces process steps and shortens reaction times, enabling reactions to occur under milder conditions. The method enhances process management and supports industrial mass production, making it a valuable contribution to the pharmaceutical industry.

Career Highlights

Yong Ho Sun is associated with Boryung Corporation, where he applies his expertise in pharmaceutical innovation. His work focuses on improving the efficiency and effectiveness of drug development processes, particularly in the area of cancer treatment.

Collaborations

Yong Ho Sun collaborates with talented colleagues, including Joon Kwang Lee and Ji Han Kim, who contribute to the research and development efforts at Boryung Corporation.

Conclusion

Yong Ho Sun's innovative methods in preparing PI3K inhibitors represent a significant advancement in pharmaceutical research. His contributions not only simplify existing processes but also pave the way for more efficient drug production.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…